← Open Payments lookup

JASON KELLOGG: Open Payments

NPI 1952331530 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$463,035 in 516 payments from 14 companies in 2025. Trend: 2023 $428,923 · 2024 $432,271 · 2025 $463,035

Speaker / faculty: $366,336Travel & lodging: $67,000Consulting: $17,320Food & beverage: $12,378
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.124$112,618
Vanda Pharmaceuticals Inc.88$87,135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)65$67,049
Janssen Pharmaceuticals, Inc68$67,030
E.R. Squibb & Sons, L.L.C.52$53,470
ACADIA Pharmaceuticals Inc60$35,925
Otsuka America Pharmaceutical, Inc.40$30,204
Teva Pharmaceuticals USA, Inc.9$9,274
Luye Pharma (USA) Ltd.3$167
Alkermes, Inc.3$67

Products named: INGREZZA, FANAPT, CAPLYTA, INVEGA SUSTENNA, COBENFY, NUPLAZID, REXULTI, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.